Drug Companies Face Lawsuit For Exposing Patients To Cancer Causing Medication Valsartan

Via America’s Lawyer: A Chinese pharmaceutical company faces a wave of lawsuits after an ingredient in their blood pressure drug Valsartan was found to cause cancer. Attorney Madeline Pendley joins Mike Papantonio to explain the case against the Zhejiang Huahai Pharmaceutical (ZHP), who knowingly manufactured and distributed the tainted medication while cutting corners in its production.

Become a member today!

Support us by becoming a monthly patron on Patreon, and help keep progressive media alive!

Find our merchandise at Teespring

Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content!

Support Ring of Fire by subscribing to our YouTube channel

Be sociable! Follow us on:

Follow more of our stories at

Subscribe to our podcast

*This transcript was generated by a third-party transcription software company, so please excuse any typos.

Drug companies are being sued by patients who took medications containing Valsartan. Instead of helping to control high blood pressure, the drugs actually cause many of them to develop cancer. Madeline Pendley, attorney Madeline Pendley is here to join me now to talk about this. Maddie, first of all, what is, what's the underlying problem here?

So the underlying problem is Valsartan, which is a generic drug. It was pulled from the market because it was contaminated with a highly carcinogenic compound known as NDMA

NDMA, people are going to start hearing more and more about NDMA because it's, now we learned that it's in so many different medications.

Right.

Tell me a little bit about it.

So NDMA it's extremely dangerous. So the only reason it's even used today is in laboratory studies. So they actually inject animals within NDMA in order to see how tumors develop. So there's no question it's carcinogenic and it's actually extremely good at facilitating tumor development. Anywhere it's injected will develop a tumor.

Okay. So the whole purpose, the only purpose that we use it for on the market in the United States is to cause cancer.

Yes.

In laboratory animals.

Exactly.

And with Valsartan we know that it's in Valsartan. It's being created, produced inside the, inside the medication itself. And, and so what went wrong? What happened here? Was it, was it contamination of some kind or what?

It's basically a manufacturing defect and this happened long story short because these companies cared more about making money than making a drug that was safe. So we have two main groups of defendants to keep it simple. API manufacturers. They make the active pharmaceutical ingredient Valsartan and finished dose manufacturers who bought that product. Basically our main API manufacturer is a Chinese manufacturer called ZHP. ZHP had been making Valsartan for years with no issue at all, and that's important, but in order to save money, they decided to change the manufacturing process, switch from process one to process two, when they did that, they used cheaper materials. They can make more drugs more quickly, you know, so it was just to make money and that process too is what facilitated NDMA in the drug.

So you're suing, you're suing these Chinese companies in the United States?

Yes.

And you, you're going to be able to hold them here, hold them accountable with that case?

Yes. And we have a ton of internal documents, things they we're saying to each other when they thought nobody was looking. Test results they had early on that shows that they did know about this issue and just didn't tell anybody.

Well, what, okay, so, so they, this Chinese company knows they're shipping tons of this stuff to the United States and all around the world for that matter.

Right.

They already know it's contaminated.

Yes.

They, there's, there's not any question, yeah, we know it's contaminated. They're trying to say to the, to the world public, don't worry about it. It's not enough. You're going to be okay.

Right.

That is the biggest lie they could possibly tell, isn't it?

Right. And they knew it was contaminated and they actually had testing results that show things that they were referring to as ghost peaks. So this is probably grossly oversimplified, over-simplify, but they have chromatography testing. It's like shows little bumps and so they know where these bumps should be in baseline clean Valsartan.

Yeah.

They did testing after the process to switch and saw these huge peaks.

And you've seen them?

#rof #trofire #theringoffire #progressivenews